Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

Prostate Cancer UK is urging the government to update NHS guidelines so that GPs can proactively start having conversations ...

After skin cancer, prostate cancer is the most common cancer in men in the US. A new treatment is giving men more options.

Vir Biotechnology's Phase 1 trials reveal promising safety and efficacy for dual-masked T-cell engagers targeting HER2 and ...

The new test has demonstrated an initial 94% sensitivity rate in tumour detection and the test is delivered in under 20 ...

Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously ... Dec. 19, 2024 — There are several ...

A novel polygenic risk score (PRS) may be useful for identifying men on active surveillance (AS) for prostate cancer who are ...

New prostate cancer imaging shows ‘extremely encouraging’ results in trials - It is hoped the new technology will cut waiting ...

Discover a study where results from the 2,129 participants revealed that Stockholm3 demonstrated non-inferior sensitivity ...